James A. Daniel, PhD
Affiliations: | 2003-2009 | Neurodegeneration Lab | Garvan Institute of Medical Research/UNSW Australia |
2009-2013 | Cell Signalling | Children's Medical Research Institute, New South Wales, Australia, Westmead, New South Wales, Australia | |
2013- | Molecular Neurobiology | Max-Planck-Institut für Multidisziplinäre Naturwissenschaften |
Area:
Synaptic transmission, dopamine, endocytosis, drug discovery, imagingWebsite:
https://www.mpinat.mpg.de/de/danielGoogle:
"James Daniel"Mean distance: 53433
Parents
Sign in to add mentorBryce Vissel | grad student | 2003-2008 | Garvan Institute |
Phillip Robinson | post-doc | 2009-2013 | Children's Medical Research Institute, New South Wales, Australia |
Nils Brose | post-doc | 2013-2016 | Max-Planck-Institut für experimentelle Medizin |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Odell LR, Jones NC, Chau N, et al. (2023) The sulfonadyns: a class of aryl sulfonamides inhibiting dynamin I GTPase and clathrin mediated endocytosis are anti-seizure in animal models. Rsc Medicinal Chemistry. 14: 1492-1511 |
Daniel JA, Elizarova S, Shaib AH, et al. (2023) An intellectual-disability-associated mutation of the transcriptional regulator impairs glutamatergic neurotransmission. Frontiers in Molecular Neuroscience. 16: 1115880 |
Elizarova S, Chouaib AA, Shaib A, et al. (2022) A fluorescent nanosensor paint detects dopamine release at axonal varicosities with high spatiotemporal resolution. Proceedings of the National Academy of Sciences of the United States of America. 119: e2202842119 |
Daniel JA, Cooper BH, Palvimo JJ, et al. (2018) Response: Commentary: Analysis of SUMO1-conjugation at synapses. Frontiers in Cellular Neuroscience. 12: 117 |
Daniel JA, Cooper BH, Palvimo JJ, et al. (2017) Analysis of SUMO1-conjugation at Synapses. Elife. 6 |
Odell LR, Abdel-Hamid MK, Hill TA, et al. (2016) Pyrimidine-Based Inhibitors of Dynamin I GTPase Activity: Competitive Inhibition at the Pleckstrin Homology Domain. Journal of Medicinal Chemistry |
Daniel JA, Chau N, Abdel-Hamid MK, et al. (2015) Phenothiazine-derived antipsychotic drugs inhibit dynamin and clathrin-mediated endocytosis. Traffic (Copenhagen, Denmark). 16: 635-54 |
McCluskey A, Daniel JA, Hadzic G, et al. (2013) Building a better dynasore: the dyngo compounds potently inhibit dynamin and endocytosis. Traffic (Copenhagen, Denmark). 14: 1272-89 |
McGeachie AB, Odell LR, Quan A, et al. (2013) Pyrimidyn compounds: dual-action small molecule pyrimidine-based dynamin inhibitors. Acs Chemical Biology. 8: 1507-18 |
Daniel JA, Malladi CS, Kettle E, et al. (2012) Analysis of synaptic vesicle endocytosis in synaptosomes by high-content screening. Nature Protocols. 7: 1439-55 |